AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI-powered healthcare innovation

AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI-powered healthcare innovation (MHRA - Medicines and Healthcare products Regulatory Agency)

) A £1 million boost to the Medicines and Healthcare products Regulatory Agency's (MHRA) pioneering AI Airlock programme will expand access to a first-of-its-kind regulatory testing ground where companies can work directly with regulators to safely test new AI-powered medical devices and explore how to bring them to patients faster, through streamlined regulations. Applications for the second round of the programme open today (23 June 2025) and …

MHRA joins safe AI network

MHRA joins safe AI network Polly Jones 25 June, 2025 MHRA joins safe AI network 25 June, 2025 The UK has joined new global network of health regulators focused on the safe, effective use of artificial intelligence (AI) in healthcare.The Medicines and Healthcare products Regulatory Agency (MHRA) will work with regulators around the world to share early warnings on safety, monitor how AI tools perform in practice, and shape international standa…

AI Breakthroughs Drive Expansion of ‘Airlock’ Testing Programme to Support AI-Powered Healthcare Innovation

A £1 million boost to the Medicines and Healthcare products Regulatory Agency’s (MHRA) pioneering AI Airlock programme will expand access to a first-of-its-kind regulatory testing ground where companies can work directly with regulators to safely test new AI-powered medical devices and explore how to bring them to patients faster, through streamlined regulations. Applications for the second round of the programme have opened and follow a success…

MHRA AI Airlock regulatory sandbox receives £1m investment

The Medicines and Healthcare products Regulatory Agency (MHRA) has received £1 million in funding for its AI Airlock regulatory sandbox programme. A regulatory sandbox is a tool which allows businesses to explore and experiment with new and innovative products, services or businesses under the supervision of a regulator. The funding will help expand access to a regulatory testing ground which allows companies to work directly with regulators to …

AI breakthrough power expansion of AHRA's 'AI Airlock" testing programme

The Medicines and Healthcare Products Regulatory Agency (MHRA) has announced a significant expansion of its pioneering ‘AI Airlock’ testing programme, designed to safely trial new artificial intelligence (AI) technologies in healthcare With a £1 million investment, the programme enters its second phase on 23 June 2025, with new applications now open for developers and companies hoping to bring AI-powered medical innovations to market. A new kind…

AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI-powered healthcare innovation

MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase.